Last Update: 06-May-13 11:21 ET
The Healthcare sector (-0.27%) is trading slightly lower today, underperforming the S&P 500
General Commentary: CombiMatrix (CBMX) is up over 8% this morning after announcing it raised $2.4 million in equity financing. The financing is through the sale of Series C convertible preferred stock and warrants. CombiMatrix has been a volatile name in the past. The company offers DNA-based testing services in the areas of POC (products of conception), prenatal, pediatric and oncology. Shares surged from $1.94 to highs of $14.16 in two days last December after the company announced that a pair of studies published in a leading journal favor chromosomal microarray analysis (CMA) over traditional karyotyping for genetic prenatal diagnosis and genetic evaluation of stillbirths. Shares also surged again in late February after the company announced annual growth in prenatal testing volumes of 172% and 171% in the fourth quarter and year.
General Commentary: CombiMatrix (CBMX) is up over 8% this morning after announcing it raised $2.4 million in equity financing. The financing is